The Clinical Trial of Stellate Ganglion Phototherapy for treatment of premature ventricular contraction.
- Conditions
- premature ventricular contraction
- Registration Number
- JPRN-jRCTs032220170
- Lead Sponsor
- Komatsu Yuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
(1) Diagnosed with premature ventricular contraction (PVC), (2) The frequency of the PVC was over 5,000 beats per day in the holter electrocardiography in 3 months before on the obtaing consent, (3) Understanding the appropriate use of super lizer mini, (4) Aged 18 to 80 on the obtaing consent, (5) Obtained written the informed consent, (6) Out patient.
(1) Diagnosed with photosensitivity disorder, (2) Low ejection fraction (under 40%) or moderate or severe valvular disease was recognized with transthoracic echocardiography in 6 months before on the obtaing consent, (3) Perceptual disorder at neck due to uncontrolled severe diabetes mellitus, (4) Uncontrolled hypertension or unstable ischemic heart disease, (5) Adjudicated inappropriate by principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method